Mark W. Empie, ADM

Vice President - Regulatory and Scientific Affairs
Archer Daniels Midland Company

Dr. Empie heads the clinical and nutraceutical research programs within the Research & Development Department of Archer Daniels Midland Company and has the additional function for new product regulatory affairs across all company divisions. Since joining ADM in 1997, he has been involved with new product identification, development and approvals; GRAS, color additive and feed ingredient submissions; health claim initiatives; GMO issues; supplement labeling; clinical and scientific substantiation for claims and advertising; various patent matters; industry organization contacts; and EU regulatory issues. Prior to joining ADM, he was a new product developer for Gist-brocades, Dow Chemical and Stauffer Chemical Companies, and he holds degrees in chemistry from Syracuse and Purdue Universities.

Corporate Overview
Archer Daniels Midland Company (ADM) is a world leader in agricultural processing and fermentation technology. ADM is one of the world’s largest processors of soybeans, corn, wheat and cocoa. ADM is also a leader in the production of soybean oil and meal, ethanol, corn sweeteners and flour. In addition, ADM produces value-added food and feed ingredients. Headquartered in Decatur, Illinois, ADM has over 26,000 employees, more than 240 processing plants and net sales for the fiscal year ended June 30, 2006 of $36.6 billion.

Web Site: www.admworld.com